# GLATIRAMER ACETATE
> **ANDA214022** · Abbreviated New Drug Application (Generic) · Sponsor: HYBIO · Approved 2026-02-11
## Drug
- **FDA Application Number:** ANDA214022
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** GLATIRAMER ACETATE
- **Generic name:** GLATIRAMER ACETATE
- **Active ingredients:** GLATIRAMER ACETATE
- **Dosage form:** INJECTABLE
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** HYBIO
- **Manufacturer:** AJENAT PHARMACEUTICALS LLC
- **First approval:** 2026-02-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214022)
---
*MORVS · CC0 1.0*